Dementia Companion Care

07/07/2026

One step closer to Parkinson's and Alzheimer's

Read and interact with this announcement: FDA Meeting Minutes Confirm Registrational Path for ATH434 on Alterity Therapeutics's investor hub

03/07/2026

https://www.facebook.com/share/p/19JXxHb4Db/?mibextid=wwXIfr

I looked after 3 ladies on my afternoon shift in an institution
For 2 years
Gave them love ,hugs and external validation .. they responded,..big improvement in their well being

Nearly half of dementia cases could be prevented, but awareness alone is not enough.

03/07/2026

https://www.facebook.com/share/p/19FWfviYqh/?mibextid=wwXIfr

I agree . I looked after 3 ladies every afternoon for 2 years .. gave them love and a heap of external validation and I noticed the change

Nearly half of dementia cases could be prevented, but awareness alone is not enough.

20/06/2026

https://www.facebook.com/share/v/1EUeJ5Uh1a/?mibextid=wwXIfr

Happened to me …dementia patient smashed my head against the wall without reason
That’s why it’s important to seek help early. Don’t feel guilty..,

17/06/2026

12/06/2026

https://v4l25d1g.r.ap-southeast-2.awstrack.me/L0/https:%2F%2Fyoutu.be%2FX3S5fvzK1S4%3Fsi=-nCaMOltWFp_4fzJ/1/0108019eba098863-a4f40ba6-5941-4b37-9243-567d59825a65-000000/fsVyCal-lTPaZh_6O2aJy12fWRg=258

For too long, Multiple Systems Atrophy (MSA) patients faced a road ...

09/06/2026

https://ausbiz.com.au/media/alterity-clears-critical-fda-hurdle-in-race-to-treat-incurable-brain-disease?videoId=49010

MSA trial reveals Parkinson’s has a similarity re make up

Key points:FDA alignment on phase three design, endpoint and 50mg dose for MSA candidatePhase two data viewed by Stamler as robust, with substantial slowing of disease progressionPeak sales for MSA treatment estimated internally at about US$2.4 billi...

09/06/2026

Today’s announcement from Alterity Therapeutics re FDA approval for their Phase 3 trial is encouraging for Parkinson’s , Alzheimer’s and all the Neurodegenerative diseases

09/06/2026

https://hotcopper.com.au/threads/ann-alterity-and-fda-agree-on-phase-3-program-for-ath434-in-msa.9189392/?post_id=84233747

First MSA then Parkinson’s then Alzheimer’s